Schott Doubles Production Capacity for Polymer Syringes

May 08, 2013
By BioPharm International Editors

Schott installed a new line in its St. Gallen, Switzerland facility to manufacture small-size (1 to 10 mL), ready-to-fill syringes made of cyclic olefin copolymer (COC), the company noted in a press release. This expansion doubles Schott’s production capacity for COC syringes.

COC is an inert material that is compatible with a broad range of drugs. Schott says its syringes have excellent barrier properties and glass-like transparency and are break-resistant and lightweight. The syringes are manufactured in cleanrooms using a fully automated process from injection molding to the final packaging. The syringes are sterilized and are ready for aseptic-filling operations.